← Cockpit
245_010predictionBiotech/LongevityAI-timing

Breaking will pursue a human-body microplastic solution (supplement) in addition to environmental plastic degradation

Predictor: Ben Lamm · ep#245 "AI + Synthetic Biology: The Most Transformative Technology in Human History | Ben Lamm (Colossal)" · source

Prior probability
45.0%
Current probability
40.6%
evolves via intake + LBP
Conviction
3/5
Signal quality
C
Resolution
pending
Window
2026-04-30 – 2029-12-31
Edges in / out
3 / 0
Tickers exposed
33

Prediction text

Breaking will pursue a human-body microplastic solution (supplement) in addition to environmental plastic degradation | And we are starting to look at the human body and and... how do we break down and get rid of plastics um you know in the world.

Verbatim quote

From episode "AI + Synthetic Biology: The Most Transformative Technology in Human History | Ben Lamm (Colossal)"
And we are starting to look at the human body and and... how do we break down and get rid of plastics um you know in the world.

Predictor: Ben Lamm

κ + Brier as of 2026-05-22
κ (discount)
0.688
Brier
0.0043
excellent
Hits / Misses
2 / 0
of 3 resolved
Hit rate
66.7%
Calibration plot (stated vs observed)

Evidence about this node from Ben Lamm is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).

Reference class

Not linked

This node isn't linked to a reference class. The Bayesian update applies without outside-view blending.

Probability over time

2 prob_history rows
0%25%50%75%100%prior 45%2026-04-302026-04-30
intake v2milestone miss sweeplbp propagationreference class assignedlegacy v1prior_prob (analyst seed)current = 40.6%

Milestone chain

Pre-event signals (upstream prereqs + window checkpoints) → resolution event → downstream cascades. Status/dates update from linked nodes; re-derive nightly via scripts/ops/derive_milestones.py.
Leading chain: 8 pending
  1. 2026-11-28pendingQ1 window check-in (25%)
  2. 2027-03-31pendingBreaking applies for or receives ARPA-H STOMP program funding
    How: ARPA-H STOMP awardee announcement names Breaking as recipient (program announced April 2026)
    Source: HHS press room ARPA-H STOMPconf 40%
  3. 2027-06-29pendingQ2 window check-in (50%)
  4. 2027-06-30pendingBreaking publishes preclinical paper or whitepaper on human-body microplastic supplement
    How: Breaking (the company) publishes peer-reviewed preprint or company whitepaper on candidate molecule for in-vivo microplastic clearance
    Source: Microplastic supplement startup space trackerconf 50%
  5. 2027-09-30pendingBreaking environmental product (plastic-degrading microbe) hits commercial scale milestone
    How: Breaking ships environmental degradation product to first municipal/industrial customer per company press release
    Source: Breaking core business prereqconf 50%
  6. 2027-06-01 → 2028-08-27pendingFirst peer-reviewed human RCT data on a microplastic-clearance intervention
    How: Any peer-reviewed RCT (Breaking or competitor) reports change in serum/tissue microplastic concentration in N>=20 healthy adults
    Source: Microplastics removal research pipelineconf 40%
  7. 2028-01-27pendingQ3 window check-in (75%)
  8. 2028-03-31pendingBreaking launches DTC supplement product or files IND with FDA
    How: Breaking website publishes consumer supplement SKU OR FDA IND filing visible in clinicaltrials.gov for microplastic-clearance candidate
    Source: Industry trajectory — Washington Post coverage of microplastic clearance startupsconf 45%

No downstream cascades — this prediction is a leaf in the dependency graph.

What if this resolves?

Clamp this prediction TRUE or FALSE and run a counterfactual Gibbs sample. Surfaces the predictions whose marginals shift most under that assumption.
(live posterior: 41%)

Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"

Evidence chain

Every probability update with full Bayesian provenance — chronological, latest first
LBP2026-04-30T16:39:51Z40.6%-1.5pp
Network propagation: 42.1% → 40.6%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v2 · run 0c8a4ea3
LBP2026-04-30T02:18:57Z42.1%-2.9pp
Network propagation: 45.0% → 42.1%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v1 · run 592311ef

Network propagation neighbors

Top edges sorted by latest LBP cross-impact
All propagation →

Top incoming (parents)

Edges that influence THIS node's belief

KindNodeTheir probP(c|s=T)P(c|s=F)Δ implied
killerTK14
Superbubble Pop (S&P 500 -40%, Moonshot Capital Evaporates)
20.0%0.0500.450-0.036
killerTK01
AGI Capability Plateau (2026-27 Training Stall)
15.0%0.0500.450-0.016
killerTK03
AI Regulatory Moratorium (EU/US Capability Freeze)
10.0%0.0500.450+0.004

Top outgoing (children)

Predictions THIS node influences

No outgoing edges.

Ticker exposure

33 ticker(s) linked

Beneficiaries (23)

SOUNCRWVSITMNVDAARMGTLBBBAITSMAPLDCEVAAIMSFTMRVLSFTBYORCLQCOMAVGOBABAAMDGOOGLIBMAMZNMETA

Adverse (6)

WNSCHGGCTSHIBMINFYACN

Prerequisites (3)

Predictions that must hit first
TypePredTitleDomainLag
killerTK14Superbubble Pop (S&P 500 -40%, Moonshot Capital Evaporates)
killerTK01AGI Capability Plateau (2026-27 Training Stall)
killerTK03AI Regulatory Moratorium (EU/US Capability Freeze)

Dependents (0)

Predictions enabled by this
TypePredTitleDomainLag
No dependents

Linked documents (6)

Auto-generated by cosine similarity from Polymarket / Manifold / EDGAR / GDELT
SimSourceTitleMarket probPolarityReviewedPublished
0.575fdaFDA ANDA090431: DOXYCYCLINE HYCLATE (DOXYCYCLINE HYCLATE) — RISINGmentionspending2026-04-09
0.572fdaFDA ANDA060469: TETRACYCLINE HYDROCHLORIDE (TETRACYCLINE HYDROCHLORIDE) — IMPAX LABSmentionspending2026-04-17
0.570fdaFDA ANDA210672: MULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — APOTEXmentionspending2026-04-09
0.568fdaFDA ANDA210273: MULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — APOTEXmentionspending2026-04-09
0.568fdaFDA ANDA090505: DOXYCYCLINE HYCLATE (DOXYCYCLINE HYCLATE) — IMPAX LABS INCmentionspending2026-04-09
0.513fdaFDA ANDA040719: METHYLPREDNISOLONE ACETATE (METHYLPREDNISOLONE ACETATE) — SANDOZmentionspending2026-04-10

Raw metadata

From Thesis_Timeline_v1.0_FINAL workbook
{
  "nia": false,
  "url": "https://www.youtube.com/watch?v=Goa6c6Qz__I",
  "mode": "ASPIRATION",
  "role": "Guest-CEO",
  "caveats": "Plastic problem requires myriad of different solutions",
  "context": "And we are starting to look at the human body and and... you're not going to have like, you know, one solution to rule them all.",
  "verbatim": "And we are starting to look at the human body and and... how do we break down and get rid of plastics um you know in the world.",
  "conv_cues": "starting to look at",
  "direction": "HAPPEN",
  "timeframe": "Near future",
  "conv_level": "MEDIUM",
  "milestones": [
    {
      "kind": "quartile_checkpoint",
      "label": "Q1 window check-in (25%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -8,
      "source_id": null,
      "expected_date": "2026-11-28",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "Breaking applies for or receives ARPA-H STOMP program funding",
      "source": "HHS press room ARPA-H STOMP",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -7,
      "source_id": null,
      "confidence": 0.4,
      "source_url": "https://www.hhs.gov/press-room/arpa-h-launches-groundbreaking-144-million-program-combat-toxic-microplastics-human-body.html",
      "expected_date": "2027-03-31",
      "research_origin": "deep_research",
      "measurement_criterion": "ARPA-H STOMP awardee announcement names Breaking as recipient (program announced April 2026)"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q2 window check-in (50%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -6,
      "source_id": null,
      "expected_date": "2027-06-29",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "Breaking publishes preclinical paper or whitepaper on human-body microplastic supplement",
      "source": "Microplastic supplement startup space tracker",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -5,
      "source_id": null,
      "confidence": 0.5,
      "source_url": "https://globalwellnessinstitute.org/global-wellness-institute-blog/2026/04/08/microplastics-watch-initiative-trends-for-2026/",
      "expected_date": "2027-06-30",
      "research_origin": "deep_research",
      "measurement_criterion": "Breaking (the company) publishes peer-reviewed preprint or company whitepaper on candidate molecule for in-vivo microplastic clearance"
    },
    {
      "kind": "llm_pre_event",
      "label": "Breaking environmental product (plastic-degrading microbe) hits commercial scale milestone",
      "source": "Breaking core business prereq",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -4,
      "source_id": null,
      "confidence": 0.5,
      "expected_date": "2027-09-30",
      "research_origin": "training",
      "measurement_criterion": "Breaking ships environmental degradation product to first municipal/industrial customer per company press release"
    },
    {
      "kind": "llm_post_event",
      "label": "First peer-reviewed human RCT data on a microplastic-clearance intervention",
      "source": "Microplastics removal research pipeline",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -3,
      "source_id": null,
      "confidence": 0.4,
      "source_url": "https://www.themahareport.com/p/hhs-launches-144m-effort-to-confront",
      "expected_date": "2028-01-13",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2028-08-27",
        "from": "2027-06-01"
      },
      "measurement_criterion": "Any peer-reviewed RCT (Breaking or competitor) reports change in serum/tissue microplastic concentration in N>=20 healthy adults"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q3 window check-in (75%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -2,
      "source_id": null,
      "expected_date": "2028-01
... (truncated)